BioNTech SE (NASDAQ:BNTX) stock ended lower on Friday, but gained about 2% for the week.
On Friday, BNTX stock fell $8.02 or 3.94% to end the session at $195.69. More than 1.52 million shares traded hands – compared to its average of 2.68 million shares. The stock opened at $204.13 and moved within a wide range of $195.48 – 205.19.
BNTX Released News This Week
May 20, 2021 – Pfizer and BioNTech Sign Agreement for Additional Supply to Turkey of 60 Million Doses of their COVID-19 Vaccine
- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the BioNTech Europe GmbH has entered into an agreement with Turkey’s Ministry of Health to supply 60 million additional doses of the companies’ COVID-19 vaccine, with an option for an additional 30 million doses.
- On December 25, 2020, the two companies announced an initial agreement to provide 30 million doses of the Pfizer-BioNTech vaccine to Turkey. This second supply agreement brings the total number of doses to be supplied to Turkey to up to 120 million, all of which will be delivered in 2021.
|SHARES OUTSTANDING||241.52 M|
|SHARE FLOAT (%)||241.51 M (100.00%)|
|% HELD BY INSTITUTIONS||12.81|
Recent Stock Performance
|+/- EMA(20)||184.08 (+6.31%)|
|+/- SMA(50)||147.43 (+32.73%)|
|+/- SMA(200)||106.46 (+83.82%)|
|CCI20||81.4194||Buy||Chaikin Money Flow||0.1762||Buy|
|MACD||14.0506||Buy||Money Flow Index||34.0112||Sell|
|STOCH (14,3)||74.3800||Buy||STOCH RSI||0.3797||Neutral|